Yang et al. also confirmed that Smad4 deficiency in hepatocytes weakened spontaneous liver injury, inflammation, fibrosis, and HCC in mice with hepatocyte-specific TAK1 deletion [17]. Here, SMAD4 is linked to hepatocellular carcinoma.